{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:23:38Z","timestamp":1793931818514,"version":"4.8.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41409-022-01787-3","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T09:03:12Z","timestamp":1661504592000},"page":"1724-1726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-6527","authenticated-orcid":false,"given":"Jessica","family":"Elliott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Ahlawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-2448","authenticated-orcid":false,"given":"H. Miles","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Van Der Weyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9210-5373","authenticated-orcid":false,"given":"Amit","family":"Khot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"1787_CR1","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","volume":"28","author":"NS Agar","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, et al. Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730\u20139.","journal-title":"J Clin Oncol"},{"key":"1787_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0678-x","volume":"20","author":"L Photiou","year":"2018","unstructured":"Photiou L, van der Weyden C, McCormack C, Miles Prince H. Systemic treatment options for advanced-stage mycosis fungoides and sezary syndrome. Curr Oncol Rep. 2018;20:32.","journal-title":"Curr Oncol Rep"},{"key":"1787_CR3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s41409-020-01197-3","volume":"56","author":"E Domingo-Domenech","year":"2021","unstructured":"Domingo-Domenech E, Duarte RF, Boumedil A, Onida F, Gabriel I, Finel H, et al. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and S\u00e9zary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2021;56:1391\u2013401.","journal-title":"Bone Marrow Transplant"},{"key":"1787_CR4","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/annonc\/mdv473","volume":"26","author":"C Hosing","year":"2015","unstructured":"Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, et al. Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. Ann Oncol. 2015;26:2490\u20135.","journal-title":"Ann Oncol"},{"key":"1787_CR5","unstructured":"Onida F, Valli V, Saporiti G, Alberti Violetti S, Grifoni F, Goldaniga M, et al. Allogeneic hematopoietic stem cell transplantation as a curative treatment strategy for patients with advanced mycosis fungoides and S\u00e9zary syndrome: 2019 update of the Milan experience [abstract]. In: 4th World Congress of Cutaneous Lymphomas; 12\u201314 February 2020; Barcelona Abstract number U-02."},{"key":"1787_CR6","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1182\/bloodadvances.2020001627","volume":"4","author":"WK Weng","year":"2020","unstructured":"Weng WK, Arai S, Rezvani A, Johnston L, Lowsky R, Miklos D, et al. Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma. Blood Adv. 2020;4:4474\u201382.","journal-title":"Blood Adv"},{"key":"1787_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fcell.2020.00851","volume":"8","author":"V Stolearenco","year":"2020","unstructured":"Stolearenco V, Namini MRJ, Hasselager SS, Gluud M, Buus TB, Willerslev-Olsen A, et al. Cellular interactions and inflammation in the pathogenesis of cutaneous T-cell lymphoma. Front Cell Dev Biol. 2020;8:851.","journal-title":"Front Cell Dev Biol"},{"key":"1787_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","volume":"116","author":"JJ Campbell","year":"2010","unstructured":"Campbell JJ, Clark RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood. 2010;116:767\u201371.","journal-title":"Blood"},{"key":"1787_CR9","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3390\/cancers12082311","volume":"12","author":"BA Campbell","year":"2020","unstructured":"Campbell BA, Scarisbrick JJ, Kim YH, Wilcox RA, McCormack C, Prince HM. Time to next treatment as a meaningful endpoint for trials of primary cutaneous lymphoma. Cancers. 2020;12:2311.","journal-title":"Cancers"},{"key":"1787_CR10","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1200\/JCO.19.00345","volume":"37","author":"MM Regan","year":"2019","unstructured":"Regan MM, Werner L, Rao S, Gupte-Singh K, Hodi FS, Kirkwood JM, et al. Treatment-free survival: a novel outcome measure of the effects of immune checkpoint inhibition\u2014a pooled analysis of patients with advanced melanoma. J Clin Oncol. 2019;37:3350\u20138.","journal-title":"J Clin Oncol"},{"key":"1787_CR11","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","volume":"148","author":"F Cetin\u00f6zman","year":"2012","unstructured":"Cetin\u00f6zman F, Jansen PM, Vermeer MH, Willemze R. Differential expression of programmed death-1 (PD-1) in S\u00e9zary syndrome and mycosis fungoides. Arch Dermatol. 2012;148:1379\u201385.","journal-title":"Arch Dermatol"},{"key":"1787_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3324\/haematol.2013.098145","volume":"99","author":"A de Masson","year":"2014","unstructured":"de Masson A, Beylot-Barry M, Bouaziz JD, Peffault de Latour R, Aubin F, Garciaz S, et al. Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. Haematologica. 2014;99:527\u201334.","journal-title":"Haematologica"},{"key":"1787_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/hon.2162","volume":"34","author":"S Shiratori","year":"2016","unstructured":"Shiratori S, Fujimoto K, Nishimura M, Hatanaka KC, Kosugi-Kanaya M, Okada K, et al. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome. Hematol Oncol. 2016;34:9\u201316.","journal-title":"Hematol Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01787-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01787-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01787-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T19:22:30Z","timestamp":1667416950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01787-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1038\/s41409-022-01787-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"24 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}